scholarly journals Treat-to-Target in Atopic Dermatitis: An International Consensus on a Set of Core Decision Points for Systemic Therapies

2021 ◽  
Vol 101 (2) ◽  
pp. adv00402
Author(s):  
M Bruin-Weller ◽  
T Biedermann ◽  
R Bissonnette ◽  
M Deleuran ◽  
P Foley ◽  
...  
2017 ◽  
Vol 35 (4) ◽  
pp. 387-397 ◽  
Author(s):  
Yael Renert-Yuval ◽  
Emma Guttman-Yassky

2019 ◽  
Vol 42 (2) ◽  
pp. 84-93 ◽  
Author(s):  
Hiraku Suga ◽  
Shinichi Sato

2018 ◽  
Vol 22 (1_suppl) ◽  
pp. 6S-9S ◽  
Author(s):  
Mark G. Kirchhof ◽  
Ian Landells ◽  
Chuck W. Lynde ◽  
Melinda J. Gooderham ◽  
Chih-ho Hong

Atopic dermatitis (AD) is a chronic, relapsing, and remitting inflammatory skin disease whose onset typically occurs early in life. AD pathophysiology includes genetic, immune, and environmental factors contributing to chronic inflammation. A rapidly evolving understanding of the pathogenesis of AD has led to the development of several treatment options for AD in adults, including topicals, phototherapy, and systemic therapies. Here, we provide a concise summary of AD pathophysiology with a focus on implications for systemic therapy.


2021 ◽  
Vol 147 (2) ◽  
pp. AB31
Author(s):  
Marco DiBonaventura ◽  
Marie-Helene Lafeuille ◽  
Bruno Emond ◽  
Mei Sheng Duh ◽  
Iman Fakih ◽  
...  

2012 ◽  
Vol 12 (4) ◽  
pp. 421-426 ◽  
Author(s):  
Kristopher S. Denby ◽  
Lisa A. Beck

2009 ◽  
Vol 38 (7) ◽  
pp. 380-387 ◽  
Author(s):  
Maren G. Shaw ◽  
Craig N. Burkhart ◽  
Dean S. Morrell

Dermatology ◽  
2017 ◽  
Vol 233 (5) ◽  
pp. 344-357 ◽  
Author(s):  
Uffe Nygaard ◽  
Christian Vestergaard ◽  
Mette Deleuran

Sign in / Sign up

Export Citation Format

Share Document